Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Feb 21, 2025, 4:00 PM EST - Market closed
Achilles Therapeutics Employees
As of December 31, 2023, Achilles Therapeutics had 215 total employees, including 204 full-time and 11 part-time employees. The number of employees decreased by 27 or -11.16% compared to the previous year.
Employees
215
Change (1Y)
-27
Growth (1Y)
-11.16%
Revenue / Employee
n/a
Profits / Employee
-$311,065
Market Cap
56.72M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 215 | -27 | -11.16% |
Dec 31, 2022 | 242 | -10 | -3.97% |
Dec 31, 2021 | 252 | 93 | 58.49% |
Dec 31, 2020 | 159 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
ACHL News
- 2 months ago - Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca - GlobeNewsWire
- 3 months ago - Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market - GlobeNewsWire
- 3 months ago - Achilles Therapeutics Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - Achilles Therapeutics Announces Strategic Update - GlobeNewsWire
- 6 months ago - Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewsWire
- 9 months ago - Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines - GlobeNewsWire
- 10 months ago - Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 10 months ago - Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire